Population Genomic Screening for Hereditary Cancer Risk: Patient Experience, Perceptions, and Downstream Clinical Outcomes
Journal of Genetic Counseling · 2026
DOI: 10.1002/jgc4.70274 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Genetic Counseling, 2026. Verfasst von Sarah English und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Health Professions, Medical University of South Carolina, Charleston, South Carolina, USA. Hauptthemen laut MEDLINE: Genetic Testing, Genetic Counseling, Genetic Predisposition to Disease, Colorectal Neoplasms, Hereditary Nonpolyposis. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Population‐wide genomic screening (PWGS) offers a novel approach to identifying individuals at risk for hereditary cancer conditions such as Hereditary Breast and Ovarian Cancer (HBOC) Syndrome and Lynch Syndrome (LS). However, limited data exist on patient experiences and clinical outcomes following result disclosure. This study evaluated participant data from In Our DNA SC, a PWGS initiative offering free, CLIA‐certified genomic screening and genetic counseling. We analyzed survey and electronic medical record data of participants who received a clinically actionable result for HBOC or LS and who agreed to post‐test genetic counseling. Surveys were administered at three time points: pre‐counseling, 30‐days post‐counseling, and 6‐months post‐counseling. Of 260 invited, 52 participants completed the full survey series. Over half of participants (55.5%) reported being surprised by their genetic test result. Overall satisfaction with the return of results was high (mean > 4.5/5). Most emotional and cognitive responses did not differ significantly between groups, however, participants with LS were significantly more likely to report feeling calm/comfortable, whereas participants with HBOC reported thinking about their results more often. Most participants engaged in follow‐up risk management: 80.8% discussed results with providers, 69.2% completed screening, and 51.9% were referred to specialists. Overall, findings support the feasibility and acceptability of PWGS in unselected populations. Future research should investigate the need for tailored support and strategies to reduce attrition to guide implementation of subsequent PWGS initiatives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Health Professions, Medical University of South Carolina, Charleston, South Carolina, USA.
- Department of Genetics and Genomics, Medical University of South Carolina, Charleston, South Carolina, USA.
- Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
- College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
- Department of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
ORCID-Profile: Ingrid Wagner, Caitlin G Allen
Zitieren
APA
English, S., Malphrus, L., Norman, S., Baker, N. L., Judge, D. P., Wagner, I., & Allen, C. G. (2026). Population Genomic Screening for Hereditary Cancer Risk: Patient Experience, Perceptions, and Downstream Clinical Outcomes. Journal of Genetic Counseling. https://doi.org/10.1002/jgc4.70274
Vancouver
English S, Malphrus L, Norman S, Baker NL, Judge DP, Wagner I, et al. Population Genomic Screening for Hereditary Cancer Risk: Patient Experience, Perceptions, and Downstream Clinical Outcomes. Journal of Genetic Counseling. 2026. doi:10.1002/jgc4.70274
BibTeX
@article{English2026,
author = {English, Sarah and Malphrus, Libby and Norman, Samantha and Baker, Nathaniel L and Judge, Daniel P and Wagner, Ingrid and Allen, Caitlin G},
title = {Population Genomic Screening for Hereditary Cancer Risk: Patient Experience, Perceptions, and Downstream Clinical Outcomes},
journal = {Journal of Genetic Counseling},
year = {2026},
doi = {10.1002/jgc4.70274}
}
EUVIMED